Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-16-006982
Filing Date
2016-08-25
Accepted
2016-08-25 17:30:58
Documents
52
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT mdit10q_jun302016.htm 10-Q 772254
  Complete submission text file 0001415889-16-006982.txt   3158877

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT mdit-20160630.xml EX-101.INS 529027
3 XBRL TAXONOMY EXTENSION SCHEMA mdit-20160630.xsd EX-101.SCH 35142
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mdit-20160630_cal.xml EX-101.CAL 50771
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mdit-20160630_def.xml EX-101.DEF 106221
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdit-20160630_lab.xml EX-101.LAB 213109
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdit-20160630_pre.xml EX-101.PRE 185394
Mailing Address 414 NORTH ORLEANS STREET SUITE 502 CHICAGO IL 60610
Business Address 414 NORTH ORLEANS STREET SUITE 502 CHICAGO IL 60610 4078490290
Medite Cancer Diagnostics, Inc. (Filer) CIK: 0000075439 (see all company filings)

EIN.: 364296006 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-00935 | Film No.: 161852360
SIC: 3841 Surgical & Medical Instruments & Apparatus